Vera J C, Rivas C I, Zhang R H, Golde D W
Program in Molecular Pharmacology and Therapeutics, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA.
Blood. 1998 Apr 1;91(7):2536-46.
Although serum concentrations of ascorbic acid seldom exceed 150 micromol/L, mature neutrophils and mononuclear phagocytes accumulate millimolar concentrations of vitamin C. Relatively little is known about the mechanisms regulating this process. The colony-stimulating factors (CSFs), which are central modulators of the production, maturation, and function of human granulocytes and mononuclear phagocytes, are known to stimulate increased glucose uptake in target cells. We show here that vitamin C uptake in neutrophils, monocytes, and a neutrophilic HL-60 cell line is enhanced by the CSFs. Hexose uptake studies and competition analyses showed that dehydroascorbic acid is taken up by these cells through facilitative glucose transporters. Human monocytes were found to have a greater capacity to take up dehydroascorbic acid than neutrophils, related to more facilitative glucose transporters on the monocyte cell membrane. Ascorbic acid was not transported by these myeloid cells, indicating that they do not express a sodium-ascorbate cotransporter. Granulocyte (G)- and granulocyte-macrophage colony-stimulating factor (GM-CSF) stimulated increased uptake of vitamin C in human neutrophils, monocytes, and HL-60 neutrophils. In HL-60 neutrophils, GM-CSF increased both the transport of dehydroascorbic acid and the intracellular accumulation of ascorbic acid. The increase in transport was related to a decrease in Km for transport of dehydroascorbic acid without a change in Vmax. Increased ascorbic acid accumulation was a secondary effect of increased transport. Triggering the neutrophils with the peptide fMetLeuPhe led to enhanced vitamin C uptake by increasing the oxidation of ascorbic acid to the transportable moiety dehydroascorbic acid, and this effect was increased by priming the cells with GM-CSF. Thus, the CSFs act at least at two distinct functional loci to increase cellular vitamin C uptake: conversion of ascorbic acid to dehydroascorbic acid by enhanced oxidation in the pericellular milieu and increased transport of DHA through the facilitative glucose transporters at the cell membrane. These results link the regulated uptake of vitamin C in human host defense cells to the action of CSFs.
尽管血清中抗坏血酸的浓度很少超过150微摩尔/升,但成熟的中性粒细胞和单核吞噬细胞会积累毫摩尔浓度的维生素C。关于调节这一过程的机制,人们了解得相对较少。集落刺激因子(CSFs)是人类粒细胞和单核吞噬细胞产生、成熟和功能的核心调节因子,已知其能刺激靶细胞增加葡萄糖摄取。我们在此表明,CSFs可增强中性粒细胞、单核细胞和嗜中性HL-60细胞系对维生素C的摄取。己糖摄取研究和竞争分析表明,脱氢抗坏血酸通过易化葡萄糖转运体被这些细胞摄取。发现人类单核细胞摄取脱氢抗坏血酸的能力比中性粒细胞更强,这与单核细胞膜上更多的易化葡萄糖转运体有关。这些髓系细胞不转运抗坏血酸,表明它们不表达钠-抗坏血酸共转运体。粒细胞(G)集落刺激因子和粒细胞-巨噬细胞集落刺激因子(GM-CSF)可刺激人类中性粒细胞、单核细胞和HL-60中性粒细胞增加对维生素C的摄取。在HL-60中性粒细胞中,GM-CSF增加了脱氢抗坏血酸的转运以及抗坏血酸在细胞内的积累。转运增加与脱氢抗坏血酸转运的Km降低有关,而Vmax没有变化。抗坏血酸积累增加是转运增加的继发效应。用肽fMetLeuPhe刺激中性粒细胞会通过增加抗坏血酸氧化为可转运部分脱氢抗坏血酸来增强维生素C摄取,并且通过用GM-CSF预处理细胞可增强这种效应。因此,CSFs至少在两个不同的功能位点发挥作用以增加细胞对维生素C的摄取:通过细胞周围环境中氧化增强将抗坏血酸转化为脱氢抗坏血酸,以及通过细胞膜上的易化葡萄糖转运体增加DHA的转运。这些结果将人类宿主防御细胞中维生素C的调节性摄取与CSFs的作用联系起来。